For instance, Goumas and coworkers have recently demonstrated the significant efficacy of a soluble sgp130Fc, with an improved affinity for the binding of IL-6/sIL-6R, in an orthotropic xenografted pancreatic ductal adenocarcinoma (PDAC)14. The gene discussed is IL6R; the disease is pancreatic ductal adenocarcinoma.